Tomasiewicz Krzysztof, Chmielewska-Badora Jolanta, Zwolinski Jacek, Murias-Brylowska Elzbieta
Department of Infectious Diseases, Medical University of Lublin, Poland.
Department of Allergology and Environmental Hazards, Institute of Rural Health, Lublin.
Ann Agric Environ Med. 2016;23(1):111-5. doi: 10.5604/12321966.1196864.
The study was designed to assess the role of some important immunologic factors with regards to both laboratory results and clinical symptoms in patients with confirmed Lyme disease. Additional examinations were carried out for co-infections with a number of tick-borne pathogens.
The study group consisted of 54 patients with Lyme disease and a group of 21 healthy controls. Serology of co-infections with Anaplasma phagocytophilum, Bartonella spp. and Babesia microti was carrieed out in all patients. Blood samples were stained using the whole-blood lysis method and analyzed concurrently on a flow cytometer FACSCalibur. Directly conjugated anti-human monoclonal antibodies against CD3, CD4, CD8, CD16, CD56, HLA-DR and CD69 were used.
No significant differences were observed with respect to thepretreatment level of CD4+ and CD8+ cells. In patients with symptoms relief and symptoms persistence, lower percentages of CD4+ and CD8+ cells were found, but with no statistical dependence. In the study group, both in patients with and without co-infections, pretreatment values of CD16+CD56+ cells did not differ significantly. In patients who did not respond to the treatment, the baseline percentage of NK cells was higher (P<0.01) than in group with clinical improvement, and lower after the treatment, whereas in patients with symptoms relief after the treatment there was an increase in the percentage of NK cells.
Co-infections with Anaplasma phagocytophilum, Bartonella spp. and Babesia microti had no impact on T-cell percentages in Lyme disease patients. There was a lower baseline percentage of NK cells in patients not responding to antibiotic treatment.
本研究旨在评估一些重要免疫因素在确诊莱姆病患者的实验室检查结果和临床症状方面所起的作用。针对多种蜱传病原体的合并感染进行了额外检查。
研究组由54例莱姆病患者和21例健康对照组成。对所有患者进行了嗜吞噬细胞无形体、巴尔通体属和微小巴贝斯虫合并感染的血清学检测。血样采用全血裂解方法染色,并在流式细胞仪FACSCalibur上同时进行分析。使用了直接偶联的抗人单克隆抗体,分别针对CD3、CD4、CD8、CD16、CD56、HLA-DR和CD69。
CD4+和CD8+细胞的治疗前水平未观察到显著差异。在症状缓解和症状持续的患者中,CD4+和CD8+细胞的百分比较低,但无统计学相关性。在研究组中,无论有无合并感染的患者,CD16+CD56+细胞的治疗前值均无显著差异。在对治疗无反应的患者中,自然杀伤细胞(NK细胞)的基线百分比高于临床症状改善组(P<0.01),治疗后则较低,而在治疗后症状缓解的患者中,NK细胞百分比有所增加。
嗜吞噬细胞无形体、巴尔通体属和微小巴贝斯虫的合并感染对莱姆病患者的T细胞百分比没有影响。对抗生素治疗无反应的患者,其NK细胞的基线百分比更低。